Y. Qi

发表

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors

C. James, J. Sarkaria, A. Bryce, 2012, Investigational New Drugs.

Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer

J. Jett, S. Mandrekar, N. Foster, 2011, Cancer.

The Purported Effects of Alcohol on Appetite and Weight in Lung Cancer Patients

S. Mandrekar, Ping Yang, J. Wampfler, 2011, Nutrition and cancer.

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

Mojun Zhu, A. Tan, A. Adjei, 2020, Investigational New Drugs.

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors

B. Costello, M. Borad, S. Alberts, 2014, Investigational New Drugs.

Phase I dose escalation study of the PKC&igr; inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer

A. Mansfield, C. Erlichman, A. Fields, 2013, Anti-cancer drugs.

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.

V. Lowe, M. Hung, M. Borad, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

J. Sloan, S. Mandrekar, J. Krook, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of the trends of estradiol level on the outcome of in vitro fertilization-embryo transfer with antagonist regimens: a single center retrospective cohort study

Y. Qi, Jianwei Zhang, Cong Pang, 2021 .

Effect of cigarette smoking on quality of life in small cell lung cancer patients.

S. Mandrekar, Ping Yang, J. Wampfler, 2012, European journal of cancer.

The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer

J. Cunningham, S. Mandrekar, Ping Yang, 2010, Supportive Care in Cancer.

Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer

S. Mandrekar, S. Hillman, D. Gandara, 2012, Cancer.

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

S. Mandrekar, S. Hillman, R. Marks, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer With Good Performance Status

S. Mandrekar, M. Aubry, A. Adjei, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

C. Rudin, R. Govindan, A. Argiris, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II trial of R-(-)-gossypol acetic acid (NSC 726190, AT-101) in patients with recurrent extensive stage small cell lung cancer (ES-SCLC).

R. Govindan, A. Argiris, M. Millward, 2010 .

Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival

S. Mandrekar, J. Katzmann, Y. Qi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.